Tag Archives: SB113

Legislative Testimony: “Right to Try” Bill would Nullify in Practice Some FDA Restrictions on Terminal Patients

right to try

Following is testimony I offered before the Alaska Senate Health and Social Services Committee in support of “Right to Try” legislation. SB113 would bypass the FDA expanded access program and allow terminally ill patients to obtain experimental drugs from manufacturers without first obtaining FDA approval. This procedure directly conflicts with the federal expanded access program […]